3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
127
Colonic Neoplasms
71
Rectal Neoplasms
56
Neoplasm Metastasis
22
Pancreatic Neoplasms
20
Stomach Neoplasms
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia
11
Carcinoma, Hepatocellular
11
Neoplasms
10
Lymphoma
10
Burkitt Lymphoma
8
Adenocarcinoma Of Esophagus
8
Cholangiocarcinoma
6
Adenocarcinoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Esophageal Neoplasms
5
Leukemia, Biphenotypic, Acute
4
Intestinal Neoplasms
4
Gastrointestinal Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Digestive System Neoplasms
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Gallbladder Neoplasms
3
Biliary Tract Neoplasms
3
Rectal Diseases
2
Neurotoxicity Syndromes
2
Interventions
Cyclophosphamide
3
Epirubicin
2
Docetaxel
2
Carboplatin
2
Capecitabine
2
Azacitidine
2
venetoclax
1
tegafur-gimeracil-oteracil
1
taxane
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pirarubicin
1
pertuzumab
1
pembrolizumab
1
olaparib
1
cc-486
1
Trastuzumab
1
Thalidomide
1
Radiotherapy
1
Radiation
1
Platinum
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Nivolumab
1
Monatide (IMS 3015)
1
Methotrexate
1
Magnetic Resonance Imaging
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pathologic Complete Response
×
Leucovorin
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled